Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Common Stock | Options Exercise | $701K | +25.6K | +44.75% | $27.34 | 82.9K | Feb 23, 2022 | Direct | F1 |
transaction | PFE | Common Stock | Tax liability | -$190K | -4.06K | -4.89% | $46.87 | 78.9K | Feb 23, 2022 | Direct | F2 |
transaction | PFE | Common Stock | Tax liability | -$651K | -12.7K | -16.09% | $51.28 | 66.2K | Feb 23, 2022 | Direct | F3, F4 |
holding | PFE | Common Stock | 2.91K | Feb 23, 2022 | By Rule 16b-3 Plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -25.6K | -100% | $0.00* | 0 | Feb 23, 2022 | Common Stock | 25.6K | $27.34 | Direct | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +22.8K | $0.00 | 22.8K | Feb 24, 2022 | Common Stock | 22.8K | $45.96 | Direct | F5 | |
transaction | PFE | Stock Appreciation Rights | Award | $0 | +20.1K | $0.00 | 20.1K | Feb 24, 2022 | Common Stock | 20.1K | $45.96 | Direct | F6 |
Id | Content |
---|---|
F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
F3 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
F4 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |
F5 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
F6 | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. |